SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-062647
Filing Date
2024-07-18
Accepted
2024-07-18 17:53:00
Documents
2
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4194
2 POWER OF ATTORNEY ea020968001ex24-1_nkgen.htm EX-24.1 5099
  Complete submission text file 0001213900-24-062647.txt   10800
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Issuer) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O NKGEN BIOTECH, INC. 3001 DAIMLER ST. SANTA ANA CA 92701
Business Address
Gottardis Marco (Reporting) CIK: 0002030962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40427 | Film No.: 241125642